OQS
CCCC icon

Occudo Quantitative Strategies’s C4 Therapeutics CCCC Stock Holding History

Occudo Quantitative Strategies’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-18,317
Closed -$150K – 770
2024
Q1 		$150K Buy
+18,317
New +$142K 0.03% 623
2023
Q1 		– Sell
-10,379
Closed -$61.2K – 931
2022
Q4 		$61.2K Sell
10,379
-21,623
-68% -$179K 0.01% 876
2022
Q3 		$281K Sell
32,002
-57,088
-64% -$593K 0.02% 866
2022
Q2 		$672K Buy
+89,090
New +$784K 0.06% 516

Other funds holding CCCC

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Occudo Quantitative Strategies's CCCC Position: Q2 2024 in Review

Occudo Quantitative Strategies sold out of C4 Therapeutics (CCCC) in Q2 2024, closing a stake of 18,317 shares — an estimated $150K sold.

Occudo Quantitative Strategies first reported a position in CCCC in Q2 2022 and held it in 4 quarters. The position peaked at $672K in Q2 2022. 115 funds tracked by Wall St. Rank hold CCCC as of Q2 2024.

  • Occudo Quantitative Strategies reported no remaining C4 Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 18,317 C4 Therapeutics shares in Q2 2024, an estimated $150K.
  • Occudo Quantitative Strategies first reported a position in C4 Therapeutics in Q2 2022 and held it in 4 quarters.
  • Occudo Quantitative Strategies's C4 Therapeutics position peaked at $672K in Q2 2022.
  • 115 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.